Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Histiocytic Necrotizing Lymphadenitis, a Benign Mimic of Lymphoma Presenting with B Symptoms

Varsha Gupta, MD, Shreya Gor, MD, Anmol S Cheema, MD, Ravneet Bajwa, MD, Carrie Edelman, MD, Ethan Jeffrey Wasserman, MD

Blood (2018) 132 (Supplement 1): 4949.

https://doi.org/10.1182/blood-2018-99-118826

Published: 2018

Journal Articles

the Clinical Impact of Impaired Natural-Killer Cell Cytotoxicity for Diagnosis and Prognostication in Adult Patients with Febrile Cytopenia Including Hemophagocytic Lymphohistiocytosis and Similar Diseases: The Results of Prospective Phase II Observational Study

Jae-Ho Yoon, MD PhD, Sung-Soo Park, Young-Woo Jeon, MD, Sung-Eun Lee, MD, Byung-Sik Cho, MD, Ki-Seong Eom, Yoo-Jin Kim, MD PhD, Seok Lee, MD PhD, Hee-Je Kim, Chang-Ki Min, MD PhD, Seok-Goo Cho, MD PhD, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD, Woo-Sung Min, Eun-Jee Oh

Blood (2017) 130 (Supplement 1): 3581.

https://doi.org/10.1182/blood.V130.Suppl_1.3581.3581

Published: 2017

Journal Articles

Kikuchi-Fujimoto disease

Branko Cuglievan, Roberto N. Miranda

Blood (2017) 129 (7): 917.

https://doi.org/10.1182/blood-2016-08-736413

Published: 2017

Journal Articles

Correlation of Expression of CD25 in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells with Response to Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Patients

Daiki Karigane, MD, Hidenori Kasahara, MD, Masatoshi Sakurai, MD PhD, Eri Matsuki, MD PhD MPH, Keiichi Tozawa, MD, Yuya Koda, MD, Takaaki Toyama, MD, Taku Kikuchi, MD, Jun Kato, MD, Takayuki Shimizu, MD PhD, Takehiko Mori, MD PhD, Yoko Yatabe, Tomoko Arai, Takayuki Mitsuhashi, MD, Mitsuru Murata, MD PhD, Hiroshi Kobayashi, MD PhD, Keiyo Takubo, MD PhD, Shinichiro Okamoto, MD PhD

Blood (2016) 128 (22): 3061.

https://doi.org/10.1182/blood.V128.22.3061.3061

Published: 2016

Journal Articles

Second Attempt to Discontinue TKI in CML Patients Who Have Sustained CMR for over 2 Years Is Rarely Successful Even with the Use of Second Generation TKIs

Eri Matsuki, MD PhD MPH, Masatoshi Sakurai, MD PhD, Daiki Karigane, MD, Hidenori Kasahara, MD, Taku Kikuchi, MD, Takayuki Shimizu, MD PhD, Kenji Yokoyama, MD PhD, Takehiko Mori, MD PhD, Shinichiro Okamoto, MD PhD

Blood (2016) 128 (22): 1887.

https://doi.org/10.1182/blood.V128.22.1887.1887

Published: 2016

Journal Articles

Long-Term Treatment with Imatinib Is Associated with Decreased Estimated Glomerular Filtration Rate and Hemoglobin Level in Patients with Chronic Myelogenous Leukemia

Masatoshi Sakurai, MD PhD, Takehiko Mori, MD PhD, Daiki Karigane, MD, Hidenori Kasahara, MD, Keiichi Tozawa, MD, Eri Matsuki, MD PhD MPH, Taku Kikuchi, MD, Jun Kato, MD, Takayuki Shimizu, MD PhD, Shinichiro Okamoto, MD PhD

Blood (2016) 128 (22): 1888.

https://doi.org/10.1182/blood.V128.22.1888.1888

Published: 2016

Journal Articles

Hemophagocytic Lymphohistiocytosis: Retrospective Analysis for Prognostic Factors

Bhagirathbhai Dholaria, MBBS, William A Hammond, MD, Amanda Shreders, MD, Sarah Robinson, MD, Taimur Sher, MD

Blood (2015) 126 (23): 4615.

https://doi.org/10.1182/blood.V126.23.4615.4615

Published: 2015

Journal Articles

Targeting Immune Suppressive Microenvironment By Immune Checkpoint Blockade in Multiple Myeloma

Gullu Topal Gorgun, PhD, Kristen Cowens, Steven Paula, Mehmet Kemal Samur, PhD, Hiroto Ohguchi, MD PhD, Ahaana Singh, Randie E White, Giada Bianchi, MD, Rikio Suzuki, MDPhD, Shohei Kikuchi, MDPhD, Takeshi Harada, MDPhD, Naoya Mimura, MD PhD, Yu-Tzu Tai, PhD, Teru Hideshima, MDPhD, Jacob P. Laubach, MD, Noopur Raje, MD, Nikhil C. Munshi, MD, Paul G. Richardson, Kenneth C. Anderson

Blood (2014) 124 (21): 27.

https://doi.org/10.1182/blood.V124.21.27.27

Published: 2014

Journal Articles

Senior Labor Study: A New Definition Of Normal Hemoglobin Values In Older Healthy Individuals

Lorenz Risch, MD, MPH, Corina Risch, Pedro Medina, Urs Nydegger, Martin Risch, Jean-Francois Lambert

Blood (2013) 122 (21): 956.

https://doi.org/10.1182/blood.V122.21.956.956

Published: 2013

Journal Articles

C-Kit Signaling Blocks B Cell Differentiation of Common Lymphoid Progenitor Cells by Negatively Regulating Stat5-Dependent Activation of Ebf Expressionc-Kit Signaling Blocks B Cell Differentiation of Common Lymphoid Progenitor Cells by Negatively Regulating Stat5-Dependent Activation of Ebf1 Expression

Oleg Kolupaev, MS, Melissa Thal, PhD, Christopher Klug, PhD

Blood (2012) 120 (21): 1209.

https://doi.org/10.1182/blood.V120.21.1209.1209

Published: 2012

Journal Articles

Kikuchi-Fujimoto Disease In the United States: Clinical and Laboratory Characteristics and Outcomes

Darcie Deaver, MS, ARNP, Mojdeh Naghashpour, MD, PhD, Lubomir Sokol, MD, PhD

Blood (2010) 116 (21): 5100.

https://doi.org/10.1182/blood.V116.21.5100.5100

Published: 2010

Journal Articles

The Clinical and Histological Characterization of Malignant Lymphoma, Kikuchi-Fujimoto Disease and L-Forms Acid-Fast Bacillus Infection

Jie He, Rui-ping Li, Jian-hua Wang, Bao-An Chen, MD, PhD

Blood (2008) 112 (11): 5275.

https://doi.org/10.1182/blood.V112.11.5275.5275

Published: 2008

Journal Articles

Novel markers of normal and neoplastic human plasmacytoid dendritic cells

Teresa Marafioti, Jennifer C. Paterson, Erica Ballabio, Kaaren K. Reichard, Sara Tedoldi, Kevin Hollowood, Michael Dictor, Martin-Leo Hansmann, Stefano A. Pileri, Martin J. Dyer, Silvano Sozzani, Ivan Dikic, Andrey S. Shaw, Tony Petrella, Harald Stein, Peter G. Isaacson, Fabio Facchetti, David Y. Mason

Blood (2008) 111 (7): 3778–3792.

https://doi.org/10.1182/blood-2007-10-117531

Published: 2008

Journal Articles

Kikuchi Disease in Korean Children: Clinical Features and Disease Courses.

Jun Eun Park, MD, PhD, Hyun Joo Jung, M.D., Chul-Ho Kim, M.D., Ph.D., Jeong Hong, M.D., Ph.D., Jae Ho Han, M.D., Ph.D.

Blood (2007) 110 (11): 2285.

https://doi.org/10.1182/blood.V110.11.2285.2285

Published: 2007

Journal Articles

Increased Expression of CD47 Is a Constant Marker in Mouse and Human Myeloid Leukemias.

Catriona Jamieson, Sidd Jaiswal, David Traver, Jason Gotlib, Mark Chao, Irving L. Weissman

Blood (2005) 106 (11): 3260.

https://doi.org/10.1182/blood.V106.11.3260.3260

Published: 2005

Journal Articles

Reversal of Rituximab-Resistant AIDS-B-NHL Clone to Chemotherapeutic Drug-Induced Apoptosis by Bortezomib and DHMEQ.

Mario Vega, PhD, Ali Jazirehi, PhD, Benjamin Bonavida, PhD

Blood (2005) 106 (11): 1516.

https://doi.org/10.1182/blood.V106.11.1516.1516

Published: 2005

Journal Articles

Sensitization of Rituximab-Sensitive and Rituximab-Resistant B-NHL Cell Lines/Clones to TRAIL-Induced Apoptosis by Bortezomib and NF-κB Inhibitors.

Ali R. Jazirehi, PhD, Benjamin Bonavida, PhD

Blood (2005) 106 (11): 1514.

https://doi.org/10.1182/blood.V106.11.1514.1514

Published: 2005

Journal Articles

Sensitization of Rituximab-Resistant Ramos RR1 and Daudi RR1 Clones to Various Chemotherapeutic Drugs by a Novel Nuclear Factor-κB Activation Inhibitor.

Ali R. Jazirehi, Ph.D., Kazeo Umezawa, Ph.D., Benjamin Bonavida, Ph.D.

Blood (2004) 104 (11): 83.

https://doi.org/10.1182/blood.V104.11.83.83

Published: 2004

NARROW

Histiocytic Necrotizing Lymphadenitis, a Benign Mimic of Lymphoma Presenting with B Symptoms

the Clinical Impact of Impaired Natural-Killer Cell Cytotoxicity for Diagnosis and Prognostication in Adult Patients with Febrile Cytopenia Including Hemophagocytic Lymphohistiocytosis and Similar Diseases: The Results of Prospective Phase II Observational Study

Kikuchi-Fujimoto disease

Correlation of Expression of CD25 in Hematopoietic Stem/Progenitor Cell Fraction of Bone Marrow Cells with Response to Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Patients

Second Attempt to Discontinue TKI in CML Patients Who Have Sustained CMR for over 2 Years Is Rarely Successful Even with the Use of Second Generation TKIs

Long-Term Treatment with Imatinib Is Associated with Decreased Estimated Glomerular Filtration Rate and Hemoglobin Level in Patients with Chronic Myelogenous Leukemia

Hemophagocytic Lymphohistiocytosis: Retrospective Analysis for Prognostic Factors

Targeting Immune Suppressive Microenvironment By Immune Checkpoint Blockade in Multiple Myeloma

Senior Labor Study: A New Definition Of Normal Hemoglobin Values In Older Healthy Individuals

Kikuchi-Fujimoto Disease In the United States: Clinical and Laboratory Characteristics and Outcomes

The Clinical and Histological Characterization of Malignant Lymphoma, Kikuchi-Fujimoto Disease and L-Forms Acid-Fast Bacillus Infection

Novel markers of normal and neoplastic human plasmacytoid dendritic cells

Kikuchi Disease in Korean Children: Clinical Features and Disease Courses.

Increased Expression of CD47 Is a Constant Marker in Mouse and Human Myeloid Leukemias.

Reversal of Rituximab-Resistant AIDS-B-NHL Clone to Chemotherapeutic Drug-Induced Apoptosis by Bortezomib and DHMEQ.

Sensitization of Rituximab-Sensitive and Rituximab-Resistant B-NHL Cell Lines/Clones to TRAIL-Induced Apoptosis by Bortezomib and NF-κB Inhibitors.

Sensitization of Rituximab-Resistant Ramos RR1 and Daudi RR1 Clones to Various Chemotherapeutic Drugs by a Novel Nuclear Factor-κB Activation Inhibitor.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only